• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Vaso Active Advanced Health Products Deliver Temporary Relief From Winter Aches & Pains

Posted on: Tuesday, 23 October 2007, 15:00 CDT

"With winter right around the corner, health products merchandisers are urged to stock a unique solution for people who will suffer from the minor aches and pains brought on by cold, damp weather conditions," said Stephen Cataldo, Marketing Director of Vaso Active Pharmaceuticals, Inc. ("Vaso Active") (VAPH.ob) (http://www.vasoactive.us).

Topical over the counter ("OTC") analgesic lotions from Vaso Active include Osteon® arthritis pain-relieving lotion and A-R Extreme® for temporary relief of minor muscle and joint pain.

"These advanced health products utilize Vaso Active's proprietary topical OTC PENtoCORE® technology and are rapidly becoming the most sought-after remedies for the pain of dealing with a North American winter," Mr. Cataldo continued. "Sometimes no matter how we dress -- in layered clothing, wearing some kind of head covering -- there is the threat of a chill. Stiffness and recurring injuries can sometimes be amplified by the chills and general unpleasantness of winter," Cataldo added.

Historically, people suffering from the aches, stiffness and increased arthritis pain of winter have had only two choices: pills that have possible side effect risk or topical products that were greasy, smelly and inconvenient to use. This is where Vaso Active's unique topical OTC PENtoCORE® technology comes into play. PENtoCORE® (formulated into Osteon and A-R Extreme) provides an effective topical product with no unpleasant odor or residue. This solves the arthritis sufferer's dilemma. Now, an arthritis sufferer can choose a topical product that does not have any of the side effects associated with pills -- and because of the PENtoCORE® technology, no obnoxious odors or greasy residue. "Safe, effective, convenient"... Just what every arthritis sufferer should have in the medicine cabinet for these long cold winter months ahead.

For some tips on how to prepare for the cold winter weather or to receive a free sample of Osteon® arthritis pain relieving lotion (limited time offer) go to: http://www.vasoactive.us/wintercold.htm.

Vaso Active products are enjoying increasing acceptance and distribution across the United States. The company's products are currently available through retail outlets including Pathmark stores, ShopRite, A&P, Super Fresh, Waldbaums, Harmon Health and Beauty and also 140 Meijer stores throughout Illinois, Indiana, Kentucky, Michigan and Ohio. Orders can also be placed online via Amazon.com, AmericaRX.com, BodyBuilding.com and AlleonPharmacy.com.

About Vaso Active

Based in Danvers, Massachusetts, Vaso Active is an early stage company focused on commercializing, marketing and selling OTC pharmaceutical products, including Osteon®, A-R Extreme®, and Termin8®, that incorporate the proprietary OTC PENtoCORE® technology.

Proprietory PENtoCORE Technology Provides High Performance Results.

The PENtoCORE technology is a topical formulation that we believe allows for the formulation of OTC products with certain "use advantages" over similar products marketed by our competitors. "Use advantages" include characteristics such as less odor, less greasy feel and less residue with a more pleasant texture. Vaso Active licenses the PENtoCORE technology from its parent company, BioChemics, Inc. ("Biochemics") (http://www.biochemics.com).

Vaso Active, incorporated in Delaware in January 2003, began its operations in January 2001 as a division of BioChemics. Biochemics is engaged in the development of transdermal and topical drug delivery systems. BioChemics which was founded in 1989 and incorporated in Delaware in 1991 is also based in Danvers, Massachusetts.

FORWARD-LOOKING STATEMENTS

Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here; however, readers should review carefully reports of documents the Company files periodically with the SEC.

Source: Business Wire

More News in this Category